MBP metabolic pharmaceuticals limited

strange trading, page-7

  1. 2,971 Posts.
    I agree...This company has a cash backing per share way in excess of the share price

    Having said that, there are many companies on the market trading below cash backing and, as things stand right now, Metabolic is only a cash shell. Until Polynovo is finalised, there is no business

    In this market there are many reasons why people are selling ( margin loans etc) I don't believe its always out of choice
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.